3 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOPending
The primary objective is to assess if there are any differences in terms of Bone Mineral Density between patients receiving the BICON-PLUS NT with an alumina reduced device surface (study group) and a group of patients receiving the BICON-PLUS with…
Approved WMOCompleted
Primary Objective:To assess Laser Detection Rates of A* and C nerve fibers in healthy study subjects.Secondary Objectives:To assess Reaction Time after selective stimulation of A* and C nerve fibers in healthy subjects